DE3025226C2 - Pterinderivate und ihre Verwendung zur radioimmunologischen Bestimmung von Pterinen - Google Patents

Pterinderivate und ihre Verwendung zur radioimmunologischen Bestimmung von Pterinen

Info

Publication number
DE3025226C2
DE3025226C2 DE3025226A DE3025226A DE3025226C2 DE 3025226 C2 DE3025226 C2 DE 3025226C2 DE 3025226 A DE3025226 A DE 3025226A DE 3025226 A DE3025226 A DE 3025226A DE 3025226 C2 DE3025226 C2 DE 3025226C2
Authority
DE
Germany
Prior art keywords
mixture
hydroxy
minutes
pteridine
erythro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE3025226A
Other languages
German (de)
English (en)
Other versions
DE3025226A1 (de
Inventor
Miki Musashino Tokyo Akino
Takeshi Yokohama Kanagawa Kato
Sadao Nagoya Aichi Matsuura
Toshiharu Nagatsu
Takashi Chiryu Aichi Sugimoto
Tokio Hachioji Tokyo Yamaguchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujifilm RI Pharma Co Ltd
Original Assignee
Fujifilm RI Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP8456879A external-priority patent/JPH0231720B2/ja
Priority claimed from JP188480A external-priority patent/JPS5699484A/ja
Application filed by Fujifilm RI Pharma Co Ltd filed Critical Fujifilm RI Pharma Co Ltd
Publication of DE3025226A1 publication Critical patent/DE3025226A1/de
Application granted granted Critical
Publication of DE3025226C2 publication Critical patent/DE3025226C2/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/534—Production of labelled immunochemicals with radioactive label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/82—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving vitamins or their receptors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DE3025226A 1979-07-04 1980-07-03 Pterinderivate und ihre Verwendung zur radioimmunologischen Bestimmung von Pterinen Expired DE3025226C2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8456879A JPH0231720B2 (ja) 1979-07-04 1979-07-04 Puterinjudotaioyobiputerinruinosokuteiho
JP188480A JPS5699484A (en) 1980-01-11 1980-01-11 Pterin derivative and determination of pterins

Publications (2)

Publication Number Publication Date
DE3025226A1 DE3025226A1 (de) 1981-01-22
DE3025226C2 true DE3025226C2 (de) 1982-07-22

Family

ID=26335174

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3025226A Expired DE3025226C2 (de) 1979-07-04 1980-07-03 Pterinderivate und ihre Verwendung zur radioimmunologischen Bestimmung von Pterinen

Country Status (8)

Country Link
US (1) US4371514A (OSRAM)
AU (1) AU526214B2 (OSRAM)
CA (1) CA1150243A (OSRAM)
DE (1) DE3025226C2 (OSRAM)
FR (1) FR2460952A1 (OSRAM)
GB (1) GB2056459B (OSRAM)
NL (1) NL8003854A (OSRAM)
SE (1) SE441529B (OSRAM)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1076495B (de) * 1954-08-17 1960-02-25 Ing Ernst Godderidge Rotierende Verdraengerpumpe
US4550109A (en) * 1984-05-31 1985-10-29 The Board Of Regents, The University Of Texas System Lipoidal biopterin compounds
DE4215275A1 (de) * 1992-05-09 1993-11-11 Merck Patent Gmbh Mittel und Verfahren zur Behandlung von Körperflüssigkeiten bei der Bestimmung von Neopterin
DE4308739C1 (de) * 1993-03-19 1994-06-23 Henning Berlin Gmbh Pterinderivate, ihre Herstellung und ihre Verwendung
US5525711A (en) * 1994-05-18 1996-06-11 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Pteridine nucleotide analogs as fluorescent DNA probes
US6562969B1 (en) * 1996-12-24 2003-05-13 Research Development Foundation Ricin inhibitors and methods for use thereof
ZA9711548B (en) * 1996-12-24 1999-06-23 Res Dev Foundation Ricin inhibitors and methods for use thereof
HUE029533T2 (en) * 2003-11-17 2017-03-28 Biomarin Pharm Inc Treatment of phenylketonuria with BH4
EP2436379A1 (en) 2004-11-17 2012-04-04 BioMarin Pharmaceutical Inc. Stable tablet formulation
US20120115244A1 (en) * 2010-11-09 2012-05-10 Abbott Laboratories Materials and methods for immunoassay of pterins
US9216178B2 (en) 2011-11-02 2015-12-22 Biomarin Pharmaceutical Inc. Dry blend formulation of tetrahydrobiopterin

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB785353A (en) * 1953-01-30 1957-10-30 Merck & Co Inc Substituted pteridine derivatives
GB785352A (en) * 1953-10-21 1957-10-30 Merck & Co Inc Preparation of pteridine derivatives
GB1458978A (en) * 1973-12-11 1976-12-22 Radiochemical Centre Ltd Saturation analysis
US4202976A (en) * 1973-09-11 1980-05-13 Bayly Russell J Selenium-75 labelled derivatives of folates
US3972991A (en) * 1974-03-18 1976-08-03 Case Western Reserve University Radioisotopic assay and binder therefor
US3989812A (en) * 1974-08-09 1976-11-02 Smithkline Instruments, Inc. Folic acid derivatives and use in radio-assay
US3988431A (en) * 1974-12-12 1976-10-26 Becton, Dickinson And Company Radioassay of folates
CA1078827A (en) * 1975-02-20 1980-06-03 Nathan Lewin Isotopically labeled derivatives of folic acid
IL49283A0 (en) * 1975-03-31 1976-05-31 Rosen I A process for the radioassay of folates and novel 125 iodinated folic acid derivatives used therein
US4028465A (en) * 1975-11-10 1977-06-07 Bio-Rad Laboratories Assay method for serum folate
US4276280A (en) * 1976-09-29 1981-06-30 Becton, Dickinson And Company Radiolabeled derivatives of folic acid
US4146602A (en) * 1977-01-27 1979-03-27 Becton, Dickinson & Company Simultaneous radioassay of folate and vitamin B12
US4136159A (en) * 1977-02-28 1979-01-23 New England Nuclear Corporation Radioassay of folates
US4135880A (en) * 1977-08-19 1979-01-23 Bio-Rad Laboratories, Inc. Folate assay with ion exchange resin bound-free separation
DE2967143D1 (en) * 1978-12-18 1984-08-30 Wachter Helmut Diagnostic method, especially for the early recognition of malignant tumors and/or viral diseases, and means to carry it out

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NICHTS-ERMITTELT

Also Published As

Publication number Publication date
GB2056459A (en) 1981-03-18
FR2460952B1 (OSRAM) 1983-05-20
DE3025226A1 (de) 1981-01-22
AU6010680A (en) 1981-10-29
NL8003854A (nl) 1981-01-06
CA1150243A (en) 1983-07-19
SE8004933L (sv) 1981-01-05
AU526214B2 (en) 1982-12-23
SE441529B (sv) 1985-10-14
US4371514A (en) 1983-02-01
FR2460952A1 (fr) 1981-01-30
GB2056459B (en) 1983-03-09

Similar Documents

Publication Publication Date Title
DE69332988T2 (de) Reagenzien zum Nachweis und zur Quantifizierung von Thyroxin in flüssigen Proben
EP0371262B1 (de) Neue Digoxigenin-Derivate und ihre Verwendung
DE2928048C2 (OSRAM)
DE2901218A1 (de) Ung von theophyllin
EP0820984B1 (de) Neue Aktivierte Amphetamine
DE3856358T3 (de) Für Tests verwendbare chemilumineszierende Ester, Thioester und Amide
DE3025226C2 (de) Pterinderivate und ihre Verwendung zur radioimmunologischen Bestimmung von Pterinen
DE4310142A1 (de) Immunologisch aktive Konjugate und ein Verfahren zu ihrer Herstellung
DE2910998A1 (de) Verfahren zur herstellung von gebundenes enzym enthaltenden produkten und deren verwendung
EP0429611B1 (de) Aminoalkylmaleimide und davon abgeleitete hapten- und antigenderivate sowie konjugate mit peptiden oder proteinen
DE68918447T2 (de) Bifunktionelle kuppler und daraus hergestellte mit radionukleid markierte zusammensetzungen.
DE2921781A1 (de) Chemilumineszent-markierte konjugate und deren verwendung zum bestimmen von liganden in fluessigen medien
DE69400709T2 (de) Pterinderivate und seine anwendung zur herstellung von immunotestverfahren
DE2921782C2 (OSRAM)
DE2608096C2 (OSRAM)
DE3000879C2 (OSRAM)
DE69232162T2 (de) Hapten-Analoge zur Verwendung in Immunoassays
DE2724762C3 (de) Cortisolderivate und radioimmunoilogisches Verfahrens
DE2604991A1 (de) Bestimmung von antipyrin
EP0599325B1 (de) Verbesserte B12-Konjugate
DE2924332C2 (OSRAM)
DE69501981T2 (de) Liganden und deren metallkomplexe
DE4004296A1 (de) Verbesserte markierte haptene, verfahren zu deren herstellung sowie verwendung dieser markierten haptene in immunoassays
EP0491282B1 (de) Pteridin-Derivate, Verfahren zu ihrer Herstellung sowie deren Verwendung zur Herstellung von Immunogenen
DE69015253T2 (de) Immunassay von Elastase-1.

Legal Events

Date Code Title Description
OAP Request for examination filed
OD Request for examination
D2 Grant after examination
8339 Ceased/non-payment of the annual fee